Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0350
-0.0120 (-25.53%)
At close: Jul 1, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $1.76 million as of July 1, 2026. Its market cap has increased by 13.31% in one year.
Market Cap
1.76M
Enterprise Value
2.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 1.76M, a decrease of -94.36%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 1.76M | 217.46% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| America Great Health | 2.12M |
| ProtoKinetix | 2.10M |
| Hepion Pharmaceuticals | 1.98M |
| inTerra Resources | 1.47M |
| International Stem Cell | 1.43M |
| Abpro Holdings | 1.32M |
| AXIM Biotechnologies | 1.31M |